MET
60
2
DG
14
2
PVH
59
-3
CVS
32
3
VIX
15
7
KHC
13
-2
ZION
56
4
DNB
58
2
PYPL
52
2
JPM
64
2
PSX
29
2
BWA
45
3
FDX
40
4
WYNN
36
2
XYL
33
2
EMN
42
2
MMM
40
3
FOX
70
-3
STX
35
-2
CNP
52
-2
MET
60
2
DG
14
2
PVH
59
-3
CVS
32
3
VIX
15
7
KHC
13
-2
ZION
56
4
DNB
58
2
PYPL
52
2
JPM
64
2
PSX
29
2
BWA
45
3
FDX
40
4
WYNN
36
2
XYL
33
2
EMN
42
2
MMM
40
3
FOX
70
-3
STX
35
-2
CNP
52
-2
Financhill
Back

Cytokinetics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
42

CYTK
Cytokinetics

Last Price:
$47.40
Seasonality Move:
7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.2% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $48.54. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.2% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
42
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
45.66

Prediction Charts

Market Cap:
5.7B
Price in USD:
48.54
Volume:
940.5K
Beta:
1.44

Technical Analysis

SMA50:
51.67
SMA100:
53.31
SMA200:
56.85
52-Wk Change:
6.19%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 48.54 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 50.57 50.96 51.98 50.15
Dec-9 51.18 50.50 51.71 50.21
Dec-10 50.38 50.55 51.26 50.12
Dec-11 50.42 50.70 50.90 49.84
Dec-12 50.29 50.24 50.68 49.52
Dec-13 50.10 48.65 50.24 48.14
Dec-16 48.61 49.02 49.58 48.54
Dec-17 48.50 47.78 49.04 47.38
Dec-18 48.00 46.36 49.40 46.00
Dec-19 46.45 46.74 47.30 45.66
Dec-20 46.85 48.96 50.32 46.85
Dec-23 49.18 48.95 49.99 47.72
Dec-24 48.85 48.53 49.11 48.00
Dec-26 48.14 48.54 48.95 47.99

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.06 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.